
Author raised problems and showed through research data some simple possibilities to achieve controlled release drug liberation. The dosage form developed during drug formulation work may influence the biological effects exerted by the active ingredients and therefore may alter the therapeutic efficacy, too. The dosage from itself includes all the chemical properties of active ingredients (salt-, ester form, polar-apolar material etc.), the physical state (crystal, amorphous, polymorphous, particle size, surface area, solvated state etc.), the value of stability and the parameters of auxiliary materials and manufacturing processes. The aim of formulation -among others-is to achieve the optimal liberation and bioavailability of drugs. The article reviews the possibilities through examples (theophylline, nitrofurantoin, phenacetin, antacids) how to make production prescriptions with high reproducibility used for the preparation of prolonged action systems with controlled release drug liberation.
Nitrofurantoin, Theophylline, Delayed-Action Preparations, Drug Design, Humans, Phenacetin, Antacids, Models, Biological
Nitrofurantoin, Theophylline, Delayed-Action Preparations, Drug Design, Humans, Phenacetin, Antacids, Models, Biological
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
